Tailored care plan shows promise for frail seniors
NCT ID NCT07623694
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a personalized management program for 115 older adults with frailty. The program includes exercise, nutrition advice, and medical adjustments, starting with a short hospital stay and continuing at home for 6 months. Researchers measure changes in daily function and exercise capacity to see if the program helps.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- personalized geriatric rehabilitation program
- What this could lead to
- If successful, this could point toward an effective way to help older adults with frailty stay independent and improve their physical fitness.
- What could go wrong
- This is a small, early-stage study with no control group, so results may not be widely applicable. The program is intensive and may be hard for some to follow long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRAILTY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Russian Research and Clinical Center for Gerontology
Moscow, 129226, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart sensors at home could spot frailty early and lend a helping hand
- Can surgery for stomach or esophageal cancer cloud the mind?
- Can a smaller incision speed recovery after heart bypass in frail seniors?
- Robot companions may shield aging caregivers from frailty
- Can a 6-Month class turn back frailty? a trial tests In-Person, online, and hybrid learning
- A 36-week exercise program may reverse frailty in older adults — a community trial puts it to the test